Skin

Health :: How fish mend a broken heart

New evidence to explain how a common tropical fish mends a broken heart may suggest methods for coaxing the damaged hearts of mammals to better heal, researchers report. The researchers found that the hearts of zebrafish harbor progenitor cells that spring into action to restore wounded heart muscle. Cells from a membrane layer that surrounds the heart, called the epicardium, follow suit, invading the wounded cardiac tissue and stimulating the growth of new blood vessels.

Health :: NCI Researchers Identify Molecular Regulator for Blood Flow in Mice

Researchers at the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), and Ohio State University, have identified a cellular protein that acts as a regulator for blood flow by blocking blood vessel relaxation induced by nitric oxide (NO). This mouse study appears in the November 2, 2006, online issue of Blood*.

Health :: Red wines’ antioxident resveratrol may extend life

The health effects of wine (and alcohol in general) are the subject of considerable ongoing study. In the USA, a boom in red wine consumption was touched off in the 1990s by ’60 Minutes’, and other news reports on the French paradox. Wine is an alcoholic beverage produced by the fermentation of the juice of fruits, usually grapes.

Health :: Staph Vaccine Shows Promise in Staphylococcus infections

By combining four proteins of Staphylococcus aureus that individually generated the strongest immune response in mice, scientists have created a vaccine that significantly protects the animals from diverse strains of the bacterium that cause disease in humans. A report describing the University of Chicago study, funded by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health, appears online this week in the Proceedings of the National Academy of Sciences.

Chronic Fatigue Syndrome :: NIH Announces Awards in Chronic Fatigue Syndrome Research

The Office of Research on Women?s Health (ORWH) and the Trans-NIH Working Group for Research in Chronic Fatigue Syndrome (CFSWG) of the National Institutes of Health (NIH) are pleased to announce seven (7) awards in Chronic Fatigue Syndrome (CFS) research. The proposed studies will help researchers understand how the diverse symptoms in CFS are related to the interactions between the immune and neurological systems ? an important step towards developing effective treatments for a disabling condition.

Macular Degeneration :: Photoswitches could restore sight to blind retinas

A research center newly created by the University of California, Berkeley, and Lawrence Berkeley National Laboratory (LBNL) aims to put light-sensitive switches in the body’s cells that can be flipped on and off as easily as a remote control operates a TV. Optical switches like these could trigger a chemical reaction, initiate a muscle contraction, activate a drug or stimulate a nerve cell – all at the flash of a light.

Lymphoma :: Berlex Oncology Evaluating Combination Therapy for Non-Hodgkin’s Lymphoma

Berlex Oncology, a business unit of Berlex Laboratories, a U.S. affiliate of Schering AG, Germany (FSE: SCH; NYSE: SHR), today announced that a national clinical study is underway investigating a new approach to treating follicular B-cell lymphoma, a sub-type of non-Hodgkin?s lymphoma (NHL). NHL is the fifth most common form of cancer in the United States, with more than 56,000 new cases diagnosed each year. Follicular B-cell lymphoma is an indolent, or slow-growing, type of NHL that comprises approximately 30% of all diagnosed cases.

Sleep :: Lonely adults get stress hormone boost next morning

A new study that takes a rare look at the physiological, social and emotional dynamics of day-to-day experiences in real-life settings shows that when older adults go to bed lonely, sad or overwhelmed, they have elevated levels of cortisol shortly after waking the next morning.

Breast Cancer :: Breast cancer gene offers promising target for drugs

Researchers at UT Southwestern Medical Center have for the first time described how multiple copies of a gene are responsible for metastases in early-stage breast cancer and poor prognosis for patients. In a study published in this week’s issue of the Proceedings of the National Academy of Sciences, the gene, called uPAR, offers a promising target for therapeutic drugs to stop or slow the progression of the disease and could serve as a screening tool for assessing which types of drugs a patient will respond to.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack